References
- Alex R, Bodmeier R. Encapsulation of water soluble drugs by a modified solvent evaporation method. I Effect of process and formulation variables on entrapment. Journal of Microencapsulation 1990; 7: 347–335
- Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymers. Biomaterials 1996; 17: 93–102
- Bouissout C, Begat P, VanderWalle C, Price R. Study of the surface mobility of PLGA microspheres using high-resolution topography measurements with the atomic force microscope. Journal of Controlled Release 2005; 101: 290–292
- Claybourn M, Gray H, Murphy D, Purnell IJ, Rowlands CC. Electron paramagnetic resonance study of gamma irradiated poly(lactide-co-glycolide) microsphere. Journal of Controlled Release 2003; 91: 431–438
- Cleek RL, Ting KC, Eskin SG, Mikos AG. Microparticles of poly(D,L-lactic-co-glycolic acid)/poly(ethylene glycol) blendsfor controlled drug delivery. Journal of Controlled Release 1997; 48: 259–268
- European Guideline. European Pharmacopeia, 5th. 2005; 1: 446
- Lewis DH. Controlled release of bioactive agents from lactide/glycolide polymers. Biodegradable polymers as drug delivery systems, M Chasier, R Langer. Marcel Dekker Inc, New York 1990; 1–41
- Montanari L, Cilurzo F, Selmin F, Conti B, Genta I, Poletti G, Orsini F, Valvo L. Poly(lactide-co-glycolide) microspheres containing bupivacaine: Comparison between gamma and beta irradiation effects. Journal of Controlled Release 2003; 90: 281–290
- Montanari L, Cilurzo F, Valvo L, Faucitano A, Buttafava A, Groppo A, Genta I, Conti B. Gamma irradiation effects on stability of poly(lactide-co-glycolide) microspheres containing clonazepam. Journal of Controlled Release 2001; 75: 317–330
- Montanari L, Costantini M, Ciranni-Signoretti E, Valvo L, Santucci M, Bartolomei M, Fattibene P, Onori S, Faucitano A, Conti B, Genta I. Gamma irradiation effects on poly(DL-lactide-co-glycolide) microspheres. Journal of Controlled Release 1998; 56: 219–229
- Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol®): PLGA nanoparticles containing vitamin E TPGS. Journal of Controlled Release 2003; 86: 33–48
- Pean JM, Boury F, Venier-Julienne MC, Menei P, Proust JE, Benoit JP. Why does PEG 400 Co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?. Pharmaceutical Research 1999; 16: 1294–1299
- Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. Journal of Controlled Release 2003; 90: 281–290
- Talmadge JE. The pharmaceutics and delivery of therapeutic polypeptides and proteins. Advanced Drug Delivery Reviews 1993; 10: 247–299